Skip to main content

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CBE ID
0083
Project
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description

Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12-month period when seen in the outpatient setting OR at each hospital discharge

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Numerator

    Patients who were prescribed beta-blocker therapy either within a 12-month period when seen in the outpatient setting OR at each hospital discharge

    Denominator

    All patients aged 18 years and older with a diagnosis of heart failure with a current or prior LVEF < 40%

    Exclusions

    Denominator Exceptions:
    Documentation of medical reason(s) for not prescribing beta-blocker therapy (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons).

    Documentation of patient reason(s) for not prescribing beta-blocker therapy (e.g., patient declined, other patient reasons).

    Documentation of system reason(s) for not prescribing beta-blocker therapy (e.g., other reasons attributable to the healthcare system).

    Testing Data Sources
  • Most Recent Endorsement Activity
    Endorsed Cardiovascular Spring Cycle 2019
    Initial Endorsement
    Next Planned Maintenance Review
    Cardiovascular Spring 2025
    Endorsement Status
    Last Updated
  • Steward Organization Email
    Steward Organization Copyright

    Copyright 2019 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.